UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Longitudinal NT-proBNP: Associations With Echocardiographic Changes and Outcomes in Heart Failure

Journal of the American Heart Association, 2024-05, Vol.13 (9), p.e032254-e032254

2024

Volltextzugriff (PDF)

Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype

ESC Heart Failure, 2021-12, Vol.8 (6), p.4572-4583

2021

Volltextzugriff (PDF)

The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55)

The Lancet regional health. Western Pacific, 2020-12, Vol.5, p.100056-100056, Article 100056

2020

Volltextzugriff (PDF)

The Singapore Heart Failure Outcomes and Phenotypes (SHOP) Study and Prospective Evaluation of Outcome in Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction (PEOPLE) Study: Rationale and Design

Journal of cardiac failure, 2013-03, Vol.19 (3), p.156-162

2013

Volltextzugriff (PDF)

Stress Echocardiography: Indications and Outcomes in Tairāwhiti Since the Introduction of Computed Tomography Coronary Angiography

Heart, lung & circulation, 2022, Vol.31, p.S35-S35

2022

Volltextzugriff (PDF)

The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS): Design and Methodology

Cardiogenetics, 2021-06, Vol.11 (2), p.84-97

2021

Volltextzugriff (PDF)

Predictors of Heart Failure Hospitalisations

Heart, lung & circulation, 2019, Vol.28, p.S57-S57

2019

Volltextzugriff (PDF)

A Comparison of Radial and Femoral Coronary Angiography in Patients From SNAPSHOT ACS, a Prospective Acute Coronary Syndrome Audit in Australia and New Zealand

Heart, lung & circulation, 2017-03, Vol.26 (3), p.258-267

2017

Volltextzugriff (PDF)

Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study

Journal of the American College of Cardiology, 2019-02, Vol.73 (6), p.629-638

2019

Volltextzugriff (PDF)

Transparency in the year of COVID-19 means tracking and publishing performance in the whole health system: progress on the public reporting of acute coronary syndrome data in New Zealand

New Zealand medical journal, 2020-08, Vol.133 (1520), p.113-119

2020

Volltextzugriff (PDF)

Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study

European heart journal, 2018-05, Vol.39 (20), p.1770-1780

2018

Volltextzugriff (PDF)

Predictors of Heart Failure Admissions and Readmissions in the Midland Region: Is a Targeted Approach to Prevention Warranted?

Heart, lung & circulation, 2017, Vol.26, p.S24-S25

2017

Volltextzugriff (PDF)

Transcatheter Aortic Valve Implantation Complicated By Acute Structural Valve Failure Requiring Immediate Valve In Valve Implantation

Heart, lung & circulation, 2010-10, Vol.19 (10), p.611-614

2010

Volltextzugriff (PDF)

Cardiovascular Risk Assessment in New Zealand: The Challenge of Targeting at Risk Populations

Heart, lung & circulation, 2016, Vol.25, p.S34-S34

2016

Volltextzugriff (PDF)

Relationship Between Soluble Transferrin Receptor and Clinical Outcomes in Patients With Heart Failure According to Ejection Fraction Phenotype: The New Zealand PEOPLE Study

Journal of cardiac failure, 2022-08, Vol.28 (8), p.1255-1263

2022

Volltextzugriff (PDF)

Relationship between socioeconomic factors, distribution of public access defibrillators and incidence of out-of-hospital cardiac arrest

Resuscitation, 2019-05, Vol.138, p.53-58

2019

Volltextzugriff (PDF)

Paired risk scores to predict ischaemic and bleeding risk twenty-eight days to one year after an acute coronary syndrome

Heart (British Cardiac Society), 2023-12, Vol.109 (24), p.1827-1836

2023

Volltextzugriff (PDF)

ANZACS-QI Heart Failure Registry: a new approach using age-stratified sampling of hospital discharges to guide quality improvement (ANZACS-QI 79)

New Zealand medical journal, 2024-07, Vol.137 (1599), p.88

2024

Volltextzugriff (PDF)

Reperfusion Practice for ST Elevation Myocardial Infarction (STEMI) in New Zealand: Observations from ANZACS-QI

Heart, lung & circulation, 2018, Vol.27, p.S11-S11

2018

Volltextzugriff (PDF)

Prescribing Performance Post-Acute Coronary Syndrome Using a Composite Medication Indicator: ANZACS-QI 24

Heart, lung & circulation, 2020-06, Vol.29 (6), p.824-834

2020

Volltextzugriff (PDF)

Primary Prevention of Cardiovascular Disease – What Happens in the Rest of the World?

Heart, lung & circulation, 2016, Vol.25, p.S36-S36

2016

Volltextzugriff (PDF)

Regional Handling and Prognostic Performance of Circulating Insulin-Like Growth Factor Binding Protein-7 in Heart Failure

JACC. Heart failure, 2023-06, Vol.11 (6), p.662-674

2023

Volltextzugriff (PDF)

Invasive Versus Medical Management of Non-ST Segment Elevation Acute Coronary Syndrome in Octogenarians in New Zealand

Heart, lung & circulation, 2019, Vol.28, p.S16-S16

2019

Volltextzugriff (PDF)

Prescribing Performance After ACS–Refinement of an ANZACS-QI Composite Medication Indicator

Heart, lung & circulation, 2017, Vol.26, p.S4-S4

2017

Volltextzugriff (PDF)

Prognostic Benefit of Myocardial Perfusion Imaging in End Stage Kidney Failure

Heart, lung & circulation, 2017, Vol.26, p.S5-S5

2017

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Aktive Filter

ThemaNew Zealand - Epidemiology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Englisch
(67)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Longitudinal NT-proBNP: Associations With Echocardiographic Changes and Outcomes in Heart Failure

Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype

The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55)

The Singapore Heart Failure Outcomes and Phenotypes (SHOP) Study and Prospective Evaluation of Outcome in Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction (PEOPLE) Study: Rationale and Design

Stress Echocardiography: Indications and Outcomes in Tairāwhiti Since the Introduction of Computed Tomography Coronary Angiography

The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS): Design and Methodology

Predictors of Heart Failure Hospitalisations

A Comparison of Radial and Femoral Coronary Angiography in Patients From SNAPSHOT ACS, a Prospective Acute Coronary Syndrome Audit in Australia and New Zealand

Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study

Transparency in the year of COVID-19 means tracking and publishing performance in the whole health system: progress on the public reporting of acute coronary syndrome data in New Zealand

Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study

Predictors of Heart Failure Admissions and Readmissions in the Midland Region: Is a Targeted Approach to Prevention Warranted?

Transcatheter Aortic Valve Implantation Complicated By Acute Structural Valve Failure Requiring Immediate Valve In Valve Implantation

Cardiovascular Risk Assessment in New Zealand: The Challenge of Targeting at Risk Populations

Relationship Between Soluble Transferrin Receptor and Clinical Outcomes in Patients With Heart Failure According to Ejection Fraction Phenotype: The New Zealand PEOPLE Study

Relationship between socioeconomic factors, distribution of public access defibrillators and incidence of out-of-hospital cardiac arrest

Paired risk scores to predict ischaemic and bleeding risk twenty-eight days to one year after an acute coronary syndrome

ANZACS-QI Heart Failure Registry: a new approach using age-stratified sampling of hospital discharges to guide quality improvement (ANZACS-QI 79)

Reperfusion Practice for ST Elevation Myocardial Infarction (STEMI) in New Zealand: Observations from ANZACS-QI

Prescribing Performance Post-Acute Coronary Syndrome Using a Composite Medication Indicator: ANZACS-QI 24

Primary Prevention of Cardiovascular Disease – What Happens in the Rest of the World?

Regional Handling and Prognostic Performance of Circulating Insulin-Like Growth Factor Binding Protein-7 in Heart Failure

Invasive Versus Medical Management of Non-ST Segment Elevation Acute Coronary Syndrome in Octogenarians in New Zealand

Prescribing Performance After ACS–Refinement of an ANZACS-QI Composite Medication Indicator

Prognostic Benefit of Myocardial Perfusion Imaging in End Stage Kidney Failure

Aktive Filter

Suchergebnisse filtern